Gyre Therapeutics (GYRE) COO sells 20,918 shares after exercising options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
GYRE THERAPEUTICS, INC. Chief Operating Officer Weiguo Ye reported an exercise-and-sell sequence in company stock. On June 9 and 10, 2026, he sold a total of 20,918 shares of common stock in open-market transactions at reported prices of $6.14 and $6.21 per share, with actual sales executed across price ranges detailed in the footnotes.
On the same dates, he exercised stock options to acquire the same total of 20,918 shares of common stock at an exercise price of $0.75 per share. Following these transactions, he directly held 700,000 shares of common stock. The options exercised were reported as vested in full, and no remaining derivative positions are listed in this filing.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 20,918 shares ($128,886)
Net Sell
6 txns
Insider
Ye Weiguo
Role
Chief Operating Officer
Sold
20,918 shs ($129K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 6,418 | $0.00 | -- |
| Exercise | Common Stock | 6,418 | $0.75 | $5K |
| Sale | Common Stock | 6,418 | $6.21 | $40K |
| Exercise | Stock Option (Right to Buy) | 14,500 | $0.00 | -- |
| Exercise | Common Stock | 14,500 | $0.75 | $11K |
| Sale | Common Stock | 14,500 | $6.14 | $89K |
Holdings After Transaction:
Stock Option (Right to Buy) — 841,501 shares (Direct, null);
Common Stock — 706,418 shares (Direct, null)
Footnotes (1)
- The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.0597 to $6.19. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.11 to $6.30. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. These options are vested in full.
Key Figures
Shares sold: 20,918 shares
Sale price June 9: $6.14 per share
Sale price June 10: $6.21 per share
+5 more
8 metrics
Shares sold
20,918 shares
Total common stock sold June 9–10, 2026
Sale price June 9
$6.14 per share
Reported weighted average sale price on June 9, 2026
Sale price June 10
$6.21 per share
Reported weighted average sale price on June 10, 2026
Options exercised
20,918 shares
Total shares acquired via option exercises
Option exercise price
$0.75 per share
Exercise price for stock options converted to common
Shares held after
700,000 shares
Direct common stock ownership after transactions
Net share change
-20,918 shares
Net buy/sell shares from transaction summary
Option expiration
October 31, 2030
Expiration date of options that were exercised
Key Terms
weighted average sale price, Stock Option (Right to Buy), derivative security, open-market sale, +1 more
5 terms
weighted average sale price financial
"The price reported represents the weighted average sale price per share."
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" for derivative entries"
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
open-market sale financial
"transaction_action: "open-market sale" for common stock transactions"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
vested in full financial
"Footnote F3 states: "These options are vested in full.""
FAQ
What insider transactions did GYRE COO Weiguo Ye report in this Form 4?
COO Weiguo Ye reported selling 20,918 shares of Gyre Therapeutics common stock while exercising stock options for the same number of shares. The activity occurred over June 9–10, 2026, in open-market transactions and option exercises disclosed in the filing.
What stock options did the GYRE COO exercise in this filing?
He exercised options covering 20,918 shares of Gyre Therapeutics common stock at an exercise price of $0.75 per share. The options were described as vested in full, and the transactions were reported as derivative exercises or conversions.